Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Lars Lundell. (2015) The physiological background behind and course of development of the first proton pump inhibitor. Scandinavian Journal of Gastroenterology 50:6, pages 680-684.
Read now
Read now
H. P. M. Festen. (1989) Profound Gastric Acid Inhibition: Advantages and Potential Hazards. Scandinavian Journal of Gastroenterology 24:sup171, pages 99-105.
Read now
Read now
A. Walan. (1989) The Clinical Utility and Safety of Omeprazole. Scandinavian Journal of Gastroenterology 24:sup166, pages 140-144.
Read now
Read now
G. Bianchi Porro & F. Parente. (1989) Omeprazole in the Treatment of Duodenal Ulcer. Scandinavian Journal of Gastroenterology 24:sup166, pages 48-53.
Read now
Read now
P. G. Farup, A. R. Rosseland, L. Halvorsen, O. K. Andersen & T. Bernklev. (1989) Duodenal Ulcer Treated with Omeprazole: Healing and Relapse Rates. Scandinavian Journal of Gastroenterology 24:9, pages 1107-1112.
Read now
Read now
A. L. Karvonen, O. Keyriläinen, A. Uusitalo, M. Salaspuro, S. Tarpila, K. Andrén & H. F. Helander. (1986) Effects of Omeprazole in Duodenal Ulcer Patients. Scandinavian Journal of Gastroenterology 21:4, pages 449-454.
Read now
Read now
B. Elander, E. Fellenius, R. Leth, L. Olbe & B. Wallmark. (1986) Inhibitory Action of Omeprazole on Acid Formation in Gastric Glands and on H+,K+-ATPase Isolated from Human Gastric Mucosa. Scandinavian Journal of Gastroenterology 21:3, pages 268-272.
Read now
Read now
J. Naesdal, T. Lind, J. Bergsåker-aspöy, T. Bernklev, P. G. Farup, R. Gillberg, L. Halvorsen, A. Kilander, S. Offergaard, A. Walan & K. A. Lloyd-Davies. (1985) The Rate of Healing of Duodenal Ulcers during Omeprazole Treatment. Scandinavian Journal of Gastroenterology 20:6, pages 691-695.
Read now
Read now
Articles from other publishers (19)
Theresa Weltermann, Christian Schulz & Lukas Macke. (2021) Effect of frequently prescribed drugs on gastric cancer risk. Best Practice & Research Clinical Gastroenterology 50-51, pages 101741.
Crossref
Crossref
Lars Olbe, Enar Carlsson & Per Lindberg. (2003) A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Nature Reviews Drug Discovery 2:2, pages 132-139.
Crossref
Crossref
Ulysses G. Meneghelli, Schlioma Zaterka, Luiz Paula Castro, Osvaldo Malafaia & Luiz Guilherme Costa Lyra. (2000) Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil. The American Journal of Gastroenterology 95:1, pages 62-66.
Crossref
Crossref
E. J. Kuipers & S. G. M. Meuwissen. 2000. Helicobacter pylori. Helicobacter pylori
255
267
.
Tetsuya SEKI, Nobuyuki OHBA, Hitoshi FUNATOMI, Kazuya UTAHASHI, Keiichiro YONEYAMA & Keiji MITAMURA. (1999) A Case of Omerpazole-induced Gynecomastia Not Ascribed to Hormonal Abnormalities. The Showa University Journal of Medical Sciences 11:1, pages 45-52.
Crossref
Crossref
Sven Erik Sjöstrand, Lars Olbe & Erik Fellenius. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors
3
20
.
M.J. Arens & J. Dent. (1993) Acid pump blockers: what are their current therapeutic roles?. Baillière's Clinical Gastroenterology 7:1, pages 95-128.
Crossref
Crossref
C‐Y. WANG, T‐H. WANG, K‐H. LAI, C‐P. SIAUW, P‐C. CHEN, K‐C. YANG, Y‐T. TSAI & J‐L. SUNG. (2008) Double‐blind comparison of omeprazole 20 mg om and ranitidine 300 mg NOCTE in duodenal ulcer: A Taiwan multi‐centre study. Journal of Gastroenterology and Hepatology 7:6, pages 572-576.
Crossref
Crossref
John A. Oates, Alastair J.J. Wood & Paul N. Maton. (1991) Omeprazole. New England Journal of Medicine 324:14, pages 965-975.
Crossref
Crossref
P. N. Maton, G. Sachs & B. Wallmark. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease
159
187
.
A. S. GUERREIRO, B. C. NEVES & M. G. QUINA. (2007)
Omeprazole in the treatment of peptic ulcers resistant to H
2
‐receptor antagonist
. Alimentary Pharmacology & Therapeutics 4:3, pages 309-313.
Crossref
Crossref
J ANDERSEN, M. STRÖM, J. NÆSDAL, K. LEIRE & A. WALAN. (2007) Intravenous omeprazole: effect of a loading dose on 24‐h intragastric pH. Alimentary Pharmacology & Therapeutics 4:1, pages 65-72.
Crossref
Crossref
A. Francavilla, C. Panella, L. Polimeno, A. Di Leo, L. Makowka, M. Barone, A. Amoruso, M. Ingrosso & T.E. Starzl. (1989) Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro. Journal of Hepatology 8:1, pages 32-41.
Crossref
Crossref
A. Walan. (1988) Omeprazole. Baillière's Clinical Gastroenterology 2:3, pages 629-640.
Crossref
Crossref
J B Jansen, P Lundborg, L C Baak, J Greve, M Ohman, C Stover, K Rohss & C B Lamers. (1988) Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.. Gut 29:1, pages 75-80.
Crossref
Crossref
Jacques de Graef & Marie-Claire Woussen-Colle. (1986) Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs. Gastroenterology 91:2, pages 333-337.
Crossref
Crossref
Jorge E. Valenzuela & Hartley Cohen. 1986. Topics in Clinical Pharmacology and Therapeutics. Topics in Clinical Pharmacology and Therapeutics
151
174
.
Karsten Lauritsen, Simon J. Rune, Peter Bytzer, Henning Kelbaek, Kaj Gotlieb Jensen, Jørgen Rask-Madsen, Flemming Bendtsen, Jøorgen Linde, Magnus Højlund, Hans Harrestrup Andersen, Knud-Mogens Møllmann, Verner R. Nissen, Lars Ovesen, Poul Schlichting, Ulrik Tage-Jensen & Henrik R. Wulff. (1985) Effect of Omeprazole and Cimetidine on Duodenal Ulcer. New England Journal of Medicine 312:15, pages 958-961.
Crossref
Crossref
H. P. M. Festen, H. A. R. E. Tuynman & S. G. M. Meuwissen. 1985. Peptic Ulcer Disease: Basic and Clinical Aspects. Peptic Ulcer Disease: Basic and Clinical Aspects
127
141
.